Resalis Therapeutics

Series-A
resalistherapeutics.com Biotech & Healthcare
Total Funding $21.6M
Latest Round $10.9M Series-A
Last Announced Jan 15, 2024
Investors Undisclosed
Decision Makers 6 Available

About Resalis Therapeutics

Resalis Therapeutics is dedicated to developing RNA-based therapies that tackle the root causes of complex metabolic disorders.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website resalistherapeutics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $10,920,000 · Series-A

    startupintros.com

  2. Capital Raise

    Raised $10,640,000 · Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Resalis Therapeutics.

Funding History

2 Rounds
Series-A equity · Jan 15, 2024
Seed equity · Feb 22, 2023

Founders & Leadership

2

Riccardo Panella

Chief Scientific Officer & Co-Founder

Work email & phone locked Unlock →

Sakari Kauppinen

Chief Technology Officer & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts